Review
Open access
SEOM‑GETTHI clinical guideline for the practical management of molecular platforms (update 2026).
N. Rodriguez Salas
J. R. De La Haba-Rodríguez
Ferran Ferragut Lloret
M. V. Vaz Salgado
Martín Oré Arce
Ana Cardeña Gutiérrez
C. Beato Zambrano
R. R. Rodríguez Alonso
Rafael López López
Jesús García-Donás Jiménez
Medicine
Abstract
Identification of molecular alterations in cancer and advances in technology have enhanced the use of molecular alterations for the diagnosis and treatment of cancer in routine clinical practice. Multi-determination platforms are now available in most Spanish hospitals. First developed in 2021, the objective of these clinical practice guidelines is to review the usefulness of molecular platforms and establish usage guidelines to direct their incorporation into clinical practice. Here, we provide updated guidelines, which include the most recent advancements in this area.